Structural Engineering of pMHC Reagents for T Cell Vaccines and Diagnostics

Chemistry and Biology

Volumn 14, Issue 8, 2007, Pages 909-922

  Mitaksov, Vesselin ^a   Truscott, Steven M ^a   Lybarger, Lonnie ^b   Connolly, Janet M ^a   Hansen, Ted H ^a   Fremont, Daved H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

CHEMBIO; MOLIMMUNO

Indexed keywords

EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; VACCINE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DIAGNOSIS; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; DIAGNOSIS; EPITOPES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; VACCINES;

EID: 34547936659     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.07.010     Document Type: Article

References (61)

1. Jones E.Y. MHC class I and class II structures. Curr. Opin. Immunol. 9 (1997) 75-79
2. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13 (1995) 587-622
3. Wilson I.A., and Fremont D.H. Structural analysis of MHC class I molecules with bound peptide antigens. Semin. Immunol. 5 (1993) 75-80
4. Natarajan K., Li H., Mariuzza R.A., and Margulies D.H. MHC class I molecules, structure and function. Rev. Immunogenet. 1 (1999) 32-46
5. Young A.C., Nathenson S.G., and Sacchettini J.C. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 9 (1995) 26-36
6. Boyd D., Hung C.F., and Wu T.C. DNA vaccines for cancer. IDrugs 6 (2003) 1155-1164
7. Porgador A., Irvine K.R., Iwasaki A., Barber B.H., Restifo N.P., and Germain R.N. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188 (1998) 1075-1082
8. Eisenlohr L.C., Yewdell J.W., and Bennink J.R. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175 (1992) 481-487
9. Del Val M., Schlicht H.J., Ruppert T., Reddehase M.J., and Koszinowski U.H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66 (1991) 1145-1153
10. Heemels M.T., and Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64 (1995) 463-491
11. Yewdell J.W., and Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17 (1999) 51-88
12. Deng Y., Yewdell J.W., Eisenlohr L.C., and Bennink J.R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158 (1997) 1507-1515
13. Romero P., Dunbar P.R., Valmori D., Pittet M., Ogg G.S., Rimoldi D., Chen J.L., Lienard D., Cerottini J.C., and Cerundolo V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188 (1998) 1641-1650
14. Greten T.F., Slansky J.E., Kubota R., Soldan S.S., Jaffee E.M., Leist T.P., Pardoll D.M., Jacobson S., and Schneck J.P. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. USA 95 (1998) 7568-7573
15. Walker E.B., Haley D., Miller W., Floyd K., Wisner K.P., Sanjuan N., Maecker H., Romero P., Hu H.M., Alvord W.G., et al. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells. Clin. Cancer Res. 10 (2004) 668-680
16. Monsurro V., Nagorsen D., Wang E., Provenzano M., Dudley M.E., Rosenberg S.A., and Marincola F.M. Functional heterogeneity of vaccine-induced CD8(+) T cells. J. Immunol. 168 (2002) 5933-5942
17. Lopez-Labrador F.X., He X.S., Berenguer M., Cheung R.C., Wright T.L., and Greenberg H.B. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. J. Immunol. Methods 287 (2004) 91-99
18. Gratama J.W., van Esser J.W., Lamers C.H., Tournay C., Lowenberg B., Bolhuis R.L., and Cornelissen J.J. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98 (2001) 1358-1364
19. Yee C., Savage P.A., Lee P.P., Davis M.M., and Greenberg P.D. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162 (1999) 2227-2234
20. Cobbold M., Khan N., Pourgheysari B., Tauro S., McDonald D., Osman H., Assenmacher M., Billingham L., Steward C., Crawley C., et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202 (2005) 379-386
21. Schott E., Bertho N., Ge Q., Maurice M.M., and Ploegh H.L. Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. Proc. Natl. Acad. Sci. U S A 99 (2002) 13735-13740
22. Savage P., Cowburn P., Clayton A., Man S., Lawson T., Ogg G., Lemoine N., McMichael A., and Epenetos A. Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice. Int. J. Cancer 98 (2002) 561-566
23. Lev A., Noy R., Oved K., Novak H., Segal D., Walden P., Zehn D., and Reiter Y. Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo. Proc. Natl. Acad. Sci. U S A 101 (2004) 9051-9056
24. Masteller E.L., Warner M.R., Ferlin W., Judkowski V., Wilson D., Glaichenhaus N., and Bluestone J.A. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 171 (2003) 5587-5595
25. Maile R., Wang B., Schooler W., Meyer A., Collins E.J., and Frelinger J.A. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J. Immunol. 167 (2001) 3708-3714
26. Yu Y.Y., Netuschil N., Lybarger L., Connolly J.M., and Hansen T.H. Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J. Immunol. 168 (2002) 3145-3149
27. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., and Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
28. Choudhuri K., Wiseman D., Brown M.H., Gould K., and van der Merwe P.A. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 436 (2005) 578-582
29. Lybarger L., Yu Y.Y., Miley M.J., Fremont D.H., Myers N., Primeau T., Truscott S.M., Connolly J.M., and Hansen T.H. Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J. Biol. Chem. 278 (2003) 27105-27111
30. Fremont D.H., Stura E.A., Matsumura M., Peterson P.A., and Wilson I.A. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92 (1995) 2479-2483
31. Garcia K.C., Degano M., Speir J.A., and Wilson I.A. Emerging principles for T cell receptor recognition of antigen in cellular immunity. Rev. Immunogenet. 1 (1999) 75-90
32. Garcia K.C., Teyton L., and Wilson I.A. Structural basis of T cell recognition. Annu. Rev. Immunol. 17 (1999) 369-397
33. Kersh G.J., Miley M.J., Nelson C.A., Grakoui A., Horvath S., Donermeyer D.L., Kappler J., Allen P.M., and Fremont D.H. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166 (2001) 3345-3354
34. Lybarger L., Wang X., Harris M.R., Virgin IV H.W., and Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity 18 (2003) 121-130
35. Connolly M.L. Solvent-accessible surfaces of proteins and nucleic acids. Science 221 (1983) 709-713
36. Miley M.J., Messaoudi I., Metzner B.M., Wu Y., Nikolich-Zugich J., and Fremont D.H. Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution. J. Exp. Med. 200 (2004) 1445-1454
37. Truscott S.M., Lybarger L., Martinko J.M., Mitaksov V.E., Kranz D.M., Connolly J.M., Fremont D.H., and Hansen T.H. Disulfide bond engineering to trap peptides in the MHC class I binding groove. J. Immunol. 178 (2007) 6280-6289
38. Oved K., Lev A., Noy R., Segal D., and Reiter Y. Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol. Immunother. 54 (2005) 867-879
39. Greten T.F., Korangy F., Neumann G., Wedemeyer H., Schlote K., Heller A., Scheffer S., Pardoll D.M., Garbe A.I., Schneck J.P., and Manns M.P. Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J. Immunol. Methods 271 (2002) 125-135
40. Chen I., Howarth M., Lin W., and Ting A.Y. Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase. Nat. Methods 2 (2005) 99-104
41. Crew M.D., Cannon M.J., Phanavanh B., and Garcia-Borges C.N. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol. Immunol. 42 (2005) 1205-1214
42. Jaramillo A., Narayanan K., Campbell L.G., Benshoff N.D., Lybarger L., Hansen T.H., Fleming T.P., Dietz J.R., and Mohanakumar T. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res. Treat. 88 (2004) 29-41
43. Huang C.H., Peng S., He L., Tsai Y.C., Boyd D.A., Hansen T.H., Wu T.C., and Hung C.F. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther. 12 (2005) 1180-1186
44. Hung C.F., Calizo R., Tsai Y.C., He L., and Wu T.C. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors. Vaccine 7 (2006) 127-135
45. Hung C.F., Calizo R., Tsai Y.C., He L., and Wu T.C. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors. Vaccine 25 (2007) 127-135
46. Hirel P.H., Schmitter M.J., Dessen P., Fayat G., and Blanquet S. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc. Natl. Acad. Sci. USA 86 (1989) 8247-8251
47. Lathrop B.K., Burack W.R., Biltonen R.L., and Rule G.S. Expression of a group II phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus in Escherichia coli: recovery and renaturation from bacterial inclusion bodies. Protein Expr. Purif. 3 (1992) 512-517
48. Primeau T., Myers N.B., Yu Y.Y., Lybarger L., Wang X., Truscott S.M., Hansen T.H., and Connolly J.M. Applications of major histocompatibility complex class I molecules expressed as single chains. Immunol. Res. 32 (2005) 109-122
49. Zhang Y., Li S., Shan M., Pan X., Zhuang K., He L., Gould K., and Tien P. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 121 (2007) 105-112
50. Kawakami Y., Eliyahu S., Jennings C., Sakaguchi K., Kang X., Southwood S., Robbins P.F., Sette A., Appella E., and Rosenberg S.A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154 (1995) 3961-3968
51. Tsai V., Southwood S., Sidney J., Sakaguchi K., Kawakami Y., Appella E., Sette A., and Celis E. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol. 158 (1997) 1796-1802
52. van der Most R.G., Murali-Krishna K., Whitton J.L., Oseroff C., Alexander J., Southwood S., Sidney J., Chesnut R.W., Sette A., and Ahmed R. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240 (1998) 158-167
53. Chen Y., Webster R.G., and Woodland D.L. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. J. Immunol. 160 (1998) 2425-2432
54. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., and Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71 (1997) 2715-2721
55. Mitaksov V., and Fremont D.H. Structural definition of the H-2Kd peptide-binding motif. J. Biol. Chem. 281 (2006) 10618-10625
56. CCP4 (Collaborative Computational Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
57. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
58. Carson M. Ribbon models of macromolecules. J. Mol. Graph. 5 (1987) 103-106
59. McDonald I.K., and Thornton J.M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238 (1994) 777-793
60. Chang H.C., Smolyar A., Spoerl R., Witte T., Yao Y., Goyarts E.C., Nathenson S.G., and Reinherz E.L. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis. J. Mol. Biol. 271 (1997) 278-293
61. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96